ENTPD2 and malignant colon neoplasm: Colon cancer cell-derived exosomes transfer ENTPD2 as an extracellular ATP scavenger, thus impairing CD8+ T-cell function by inhibiting P2 X7R-mediated NFATc1 activation and promoting the activity of the adenosine-A2AR pathway.